SFE-AFCE-SFMN 2022 Consensus on the management of thyroid nodules : Thyroid nodules and pregnancy |
| |
| Affiliation: | 1. Nantes Université, CHU Nantes, Service d’Endocrinologie-Diabétologie et Nutrition, Institut du Thorax, 44000 Nantes, France;2. Service d’Endocrinologie-Diabétologie Nutrition, et Centre de Référence des Maladies Rares de la Thyroïde et des Récepteurs Hormonaux, CHU Angers, Univ Angers, Inserm, CNRS, MITOVASC, 49000 Angers, France;3. Service de Chirurgie Générale, Endocrinienne et Métabolique, APHM, Aix Marseille Université, Marseille, France;4. Nantes Université, CHU Nantes, Service d’Oncologie Médicale, 44000 Nantes, France;5. Fédération d’Endocrinologie, Groupement Hospitalier Est, Hospices Civils de Lyon; inserm U1290, Université Claude Bernard Lyon 1, Lyon, France;6. Service d’Endocrinologie et Maladies Métaboliques, CHU Larrey, Toulouse, France;1. CHU Lille, Department of Diabetology, Endocrinology, Metabolism and Nutrition, Lille University Hospital, 59000 Lille, France;2. Center for rare endocrine diseases of growth and development, ERN-HCP, Sorbonne University, Endocrinology, Diabetology and Reproductive Medicine, Saint-Antoine Hospital, AP-HP, 75012 Paris, France;3. CHU Brest, Department of Diabetology and Endocrinology, Brest University Hospital, 29200 Brest, France;1. Division of Pediatric Endocrinology, Children’s Healthcare of Atlanta, Emory University School of Medicine, 1400 Tullie Road Northeast, Atlanta, GA 30329, USA;2. Division of Endocrinology, Metabolism & Lipids, Emory University School of Medicine, 69 Jesse Hill Jr Drive Southeast, Glenn Building, Atlanta, GA 30303, USA;1. Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU de Liège, Liège, Belgium;2. Division of Clinical Pharmacology, Centre for Interdisciplinary Research on Medicines (CIRM), University of Liège, Liège, Belgium;1. Centre hospitalier universitaire Ambroise-Paré, service d’endocrinologie diabétologie et nutrition, Assistance publique–Hôpitaux de Paris, 9, avenue Charles-De-Gaulle, 92100 Boulogne-Billancourt, France;2. Centre hospitalier universitaire Raymond-Poincaré, service de médecine physique et de réadaptation, Assistance publique–Hôpitaux de Paris, 92380 Garches, France;3. EA4340, université de Versailles Saint-Quentin-en-Yvelines, UFR des sciences de la santé Simone-Veil, 78423 Montigny-le-Bretonneux, France;1. Département d’endocrinologie-diabétologie nutrition, CHU d’Angers, 4, rue larrey, 49100 Angers, France;2. Laboratoire MITOVASC, UMR CNRS 6015, Inserm 1083, Université d’Angers, rue Roger Amsler, 49100 Angers, France;3. Centre de référence des maladies rares de la Thyroïde et des Récepteurs Hormonaux, Endo-ERN centre for rare endocrine diseases. CHU d’Angers, 4, rue larrey, 49100 Angers, France |
| |
| Abstract: | The SFE-AFCE-SFMN 2022 consensus deals with the management of thyroid nodules, a condition that is a frequent reason for consultation in endocrinology. In more than 90% of cases, patients are euthyroid, with benign non-progressive nodules that do not warrant specific treatment. The clinician's objective is to detect malignant thyroid nodules at risk of recurrence and death, toxic nodules responsible for hyperthyroidism or compressive nodules warranting treatment.The diagnosis and treatment of thyroid nodules requires close collaboration between endocrinologists, nuclear medicine physicians and surgeons, but also involves other specialists. Therefore, this consensus statement was established jointly by 3 societies: the French Society of Endocrinology (SFE), French Association of Endocrine Surgery (AFCE) and French Society of Nuclear Medicine (SFMN); the various working groups included experts from other specialties (pathologists, radiologists, pediatricians, biologists, etc.). The present section deals with the epidemiology and specificities of diagnosis and treatment of thyroid nodules in pregnant women. |
| |
| Keywords: | Thyroid nodules Pregnancy Surgery Thyroid cancer Consensus |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
